{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:30:41Z","timestamp":1771327841452,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1007\/s10620-005-2571-3","type":"journal-article","created":{"date-parts":[[2005,3,31]],"date-time":"2005-03-31T14:28:00Z","timestamp":1112279280000},"page":"767-773","source":"Crossref","is-referenced-by-count":27,"title":["Leukocytapheresis (LCAP) for Management of Fulminant Ulcerative Colitis with Toxic Megacolon"],"prefix":"10.1007","volume":"50","author":[{"given":"Koji","family":"Sawada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akimitsu","family":"Egashira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunio","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kusaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Shimoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1111\/j.1572-0241.2003.07696.x","volume":"98","author":"SI Gan","year":"2003","unstructured":"Gan SI, Beck PL: A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management. Am J Gastroenterol 98:2363?2371, 2003","journal-title":"Am J Gastroenterol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0140-6736(97)10475-5","volume":"351","author":"SG Sheth","year":"1998","unstructured":"Sheth SG, LaMont JT: Toxic megacolon. Lancet 351:509?513, 1998","journal-title":"Lancet"},{"key":"CR3","unstructured":"LaMont JT, Kandel GP: Toxic megacolon in ulcerative colitis. Early diagnosis and management. Hosp Pract (Off Ed) 1986:21"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1136\/gut.34.12.1726","volume":"34","author":"MZ Panos","year":"1993","unstructured":"Panos MZ, Wood MJ, Asquith P: Toxic megacolon: the knee-elbow position relieves bowel distension. Gut 34:1726?1727, 1993","journal-title":"Gut"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00004836-198810000-00004","volume":"10","author":"DH Present","year":"1988","unstructured":"Present DH, Wolfson D, Gelernt IM, et al.: Medical decompression of toxic megacolon by ?rolling.? A new technique of decompression with favorable long-term follow-up. J Clin Gastroenterol 10:485?490, 1988","journal-title":"J Clin Gastroenterol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF00591317","volume":"3","author":"L Riedler","year":"1989","unstructured":"Riedler L, Wohlgenannt D, Stoss F, et al.: Endoscopic decompression in ?toxic megacolon.? Surg Endosc 3:51?53, 1989","journal-title":"Surg Endosc"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0140-6736(05)74837-6","volume":"353","author":"MR Welfare","year":"1999","unstructured":"Welfare MR, Barton JR, Cobden I: Hyperbaric oxygen for toxic megacolon. Lancet 353:70?71, 1999","journal-title":"Lancet"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2214\/ajr.145.5.1057","volume":"145","author":"S Momoshima","year":"1985","unstructured":"Momoshima S, Kohda E, Hiramatsu K, Asakura H: Intra-arterial prednisolone infusion therapy in ulcerative colitis. AJR 145:1057?1060, 1985","journal-title":"AJR"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0300-5089(21)00012-2","volume":"10","author":"SC Truelove","year":"1981","unstructured":"Truelove SC, Marks CG: Toxic megacolon. Part I: Pathogenesis, diagnosis and treatment. Clin Gastroenterol 10:107?117, 1981","journal-title":"Clin Gastroenterol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00004836-199307000-00004","volume":"17","author":"GC Actis","year":"1993","unstructured":"Actis GC, Ottobrelli A, Pera A, et al.: Continuously infused cyclosporine at low dose is sufficient to avoid emergency colectomy in acute attacks of ulcerative colitis without the need for high-dose steroids. J Clin Gastroenterol 17:10?13, 1993","journal-title":"J Clin Gastroenterol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00384-002-0458-8","volume":"18","author":"M Pascu","year":"2003","unstructured":"Pascu M, Muller AR, Wiedenmann B, Dignass AU: Rescue therapy with tacrolimus in a patient with toxic megacolon. Int J Colorectal Dis 18:271?275, 2003","journal-title":"Int J Colorectal Dis"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF01072276","volume":"22","author":"WA Hartong","year":"1977","unstructured":"Hartong WA, Arvanitakis C, Skibba RM, Klotz AP: Treatment of toxic megacolon. A comparative review of 29 patients. Am J Dig Dis 22:195?200, 1977","journal-title":"Am J Dig Dis"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00000658-198001000-00015","volume":"191","author":"MB Grieco","year":"1980","unstructured":"Grieco MB, Bordan DL, Geiss AC, Beil AR Jr: Toxic megacolon complicating Crohn?s colitis. Ann Surg 191:75?80, 1980","journal-title":"Ann Surg"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/BF02347507","volume":"30","author":"K Sawada","year":"1995","unstructured":"Sawada K, Ohnishi K, Fukui S, et al.: Leukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease. J Gastroenterol 30:322?329, 1995","journal-title":"J Gastroenterol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1744-9987.1997.tb00138.x","volume":"1","author":"K Sawada","year":"1997","unstructured":"Sawada K, Ohnishi K, Kosaka T, et al.: Leukocytapheresis with leukocyte removal filter as new therapy for ulcerative colitis. Ther Apheresis 1:207?211, 1997","journal-title":"Ther Apheresis"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/1381612033391928","volume":"9","author":"K Sawada","year":"2003","unstructured":"Sawada K, Muto T, Shimoyama T, et al.: Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column. Cur Pharm Design 9:307?321, 2003","journal-title":"Cur Pharm Design"},{"key":"CR17","first-page":"S66","volume":"46","author":"K Sawada","year":"2003","unstructured":"Sawada K: Leukocytapheresis as an adjunct to conventional medication for inflammatory bowel disease. Dis Colon Rectum 46:S66?S77, 2003","journal-title":"Dis Colon Rectum"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1526-0968.2003.00009.x","volume":"7","author":"H Shibata","year":"2003","unstructured":"Shibata H, Kuriyama T, Yamawaki N: Cellsorba. Ther Apher Dial 7:44?47, 2003","journal-title":"Ther Apher Dial"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1254\/jjp.35.203","volume":"35","author":"T Aoyama","year":"1984","unstructured":"Aoyama T, Ino Y, Ozeki M, et al.: Pharmacological studies of FUT-175, Nafamostat Mesilate. Inhibition of protease activity in in vitro and in vivo experiments. Jpn J Pharmacol 35:203?227, 1984","journal-title":"Jpn J Pharmacol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/bmj.298.6666.82","volume":"298","author":"D Rachmilewitz","year":"1989","unstructured":"Rachmilewitz D: On behalf of an international study group (Israel). Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomized trial. Br Med J 298:82?86, 1989","journal-title":"Br Med J"},{"key":"CR21","unstructured":"Matts SGF: The value of rectal biopsy in the diagnosis of ulcerative colitis. Quart J Med 393?400, 1961"},{"key":"CR22","first-page":"357","volume":"231","author":"T Obayashi","year":"1987","unstructured":"Obayashi T, Tamura H, Tanaka S, et al.: Removal of limulus test interfering factors in blood samples with perchloric acid and the improvement of the specificity of the limulus test by fractionating amebocyte lysate. Prog Clin Biol Res 231:357?369, 1987","journal-title":"Prog Clin Biol Res"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jca.1000","volume":"16","author":"T Shimoyama","year":"2001","unstructured":"Shimoyama T, Sawada K, Hiwatashi N, et al.: Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: A multicenter study. J Clin Apheresis 16:1?9, 2001","journal-title":"J Clin Apheresis"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1023\/A:1020159932758","volume":"47","author":"H Hanai","year":"2002","unstructured":"Hanai H, Watanabe F, Saniabadi A, et al.: Therapeutic efficacy of granulocyte and monocyte adsorption apheresis in severe active ulcerative colitis. Dig Dis Sci 47:2349?2353, 2002","journal-title":"Dig Dis Sci"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/jcgh.2003.50005","volume":"1","author":"H Hanai","year":"2003","unstructured":"Hanai H, Watanabe F, Takeuchi K, et al.: Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study. Clin Gastroenterol Hepatol 1:28?35, 2003","journal-title":"Clin Gastroenterol Hepatol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2169\/internalmedicine.38.102","volume":"38","author":"T Kosaka","year":"1999","unstructured":"Kosaka T, Sawada K, Ohnishi K, et al.: Effect of leukocytapheresis therapy using a leukocyte removal filter in Crohn?s disease. Intern Med 38:102?111, 1999","journal-title":"Intern Med"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/1529-0131(199904)42:3<431::AID-ANR6>3.0.CO;2-2","volume":"42","author":"T Hidaka","year":"1999","unstructured":"Hidaka T, Suzuki K, Matsuki Y, et al.: Filtration leukocytapheresis therapy in rheumatoid arthritis: A randomized, double-blind, placebo-controlled trial. Arth Rheum 42:431?437, 1999","journal-title":"Arth Rheum"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF00290518","volume":"15","author":"J Fujimori","year":"1996","unstructured":"Fujimori J, Yoshino S: Improvement in rheumatoid arthritis following application of a granulotrap column, G-1. Rheumatol Int 15:175?180, 1996","journal-title":"Rheumatol Int"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1525-1594.1997.tb00513.x","volume":"21","author":"M Ohara","year":"1997","unstructured":"Ohara M, Saniabadi AR, Kokuma S, et al.: Granulocytapheresis in the treatment of patients with rheumatoid arthritis. Artif Organs 21:989?994, 1997","journal-title":"Artif Organs"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/rheumatology\/39.2.165","volume":"39","author":"Y Ueki","year":"2000","unstructured":"Ueki Y, Yamasaki S, Kanamoto Y, et al.: Evaluation of filtration leucocytapheresis for use in the treatment of patients with rheumatoid arthritis. Rheumatology (Oxford) 39:165?171, 2000","journal-title":"Rheumatology (Oxford)"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(05)77809-0","volume":"352","author":"T Furuta","year":"1998","unstructured":"Furuta T, Hotta O, Yusa N, Horigome I, Chiba S, Taguma Y: Lymphocytapheresis to treat rapidly progressive glomerulonephritis: a randomised comparison with steroid-pulse treatment. Lancet 352:203?204, 1998","journal-title":"Lancet"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/jca.1016","volume":"16","author":"T Hidaka","year":"2001","unstructured":"Hidaka T, Suzuki K, Kawakami M, et al.: Dynamic changes in cytokine levels in serum and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis. J Clin Apheresis 16:74?81, 2001","journal-title":"J Clin Apheresis"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2249.1991.tb02958.x","volume":"86","author":"DA McCarthy","year":"1991","unstructured":"McCarthy DA, Rampton DS, Liu Y-C: Peripheral blood neutrophils in inflammatory bowel disease: morphological evidence of in vivo activation in active disease. Clin Exp Immunol 86:489?493, 1991","journal-title":"Clin Exp Immunol"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0016-5085(78)90285-8","volume":"74","author":"G Meuret","year":"1978","unstructured":"Meuret G, Bitzi A, Hammer B: Macrophage turnover in Crohn?s disease and ulcerative colitis. Gastroenterology 74:501?503, 1978","journal-title":"Gastroenterology"},{"key":"CR35","first-page":"91","volume-title":"Inflammatory Bowel Disease","year":"1998","unstructured":"Allison MC, Dhillon AP, Lewis WG, Pounder RE (eds): Inflammatory Bowel Disease. London, Mosby, 1998, pp 91?95"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/gast.2000.8523","volume":"119","author":"JA Tibble","year":"2000","unstructured":"Tibble JA, Sigthorsson G, Bridger D, Fagerhol MK, Bjarnason I: Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 119:15?22, 2000","journal-title":"Gastroenterology"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMra020831","volume":"347","author":"DK Podolsky","year":"2002","unstructured":"Podolsky DK: Inflammatory bowel disease. N Engl J Med 347:417?429, 2002","journal-title":"N Engl J Med"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-005-2571-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-005-2571-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-005-2571-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T15:23:11Z","timestamp":1625671391000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-005-2571-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["2571"],"URL":"https:\/\/doi.org\/10.1007\/s10620-005-2571-3","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}